相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation
M. K. Tembhre et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes
Andrea Del Fattore et al.
CELL TRANSPLANTATION (2015)
Low programmed cell death-1 (PD-1) expression in peripheral CD4+ T cells in Japanese patients with autoimmune type 1 diabetes
R. Fujisawa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study
J. Baraut et al.
BONE MARROW TRANSPLANTATION (2014)
Alteration of Regulatory T Cells in Type 1 Diabetes Mellitus: A Comprehensive Review
Tingting Tan et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2014)
Leukocyte Profiles Differ Between Type 1 and Type 2 Diabetes and Are Associated With Metabolic Phenotypes: Results From the German Diabetes Study (GDS)
Barbara Menart-Houtermans et al.
DIABETES CARE (2014)
Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells
Hiromasa Morikawa et al.
IMMUNOLOGICAL REVIEWS (2014)
Altered B Cell Homeostasis and Toll-Like Receptor 9-Driven Response in Type 1 Diabetes Carriers of the C1858T PTPN22 Allelic Variant: Implications in the Disease Pathogenesis
Elena Gianchecchi et al.
PLOS ONE (2014)
Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
Elena Gianchecchi et al.
AUTOIMMUNITY REVIEWS (2013)
Decreased CD127 Expression on CD4+T-Cells and Elevated Frequencies of CD4+CD25+CD127-T-Cells in Children with Long-Lasting Type 1 Diabetes
Marcin Moniuszko et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
CD4+CD45RA-FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes
F. Haseda et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
PD-1, but Not PD-L1, Expressed by Islet-Reactive CD4+ T Cells Suppresses Infiltration of the Pancreas During Type 1 Diabetes
Kristen E. Pauken et al.
DIABETES (2013)
Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients
Cristina Xufre et al.
INTERNATIONAL IMMUNOLOGY (2013)
Blockade of Programmed Death-1 in Young (New Zealand Black x New Zealand White)F1 Mice Promotes the Suppressive Capacity of CD4+ Regulatory T Cells Protecting from Lupus-like Disease
Maida Wong et al.
JOURNAL OF IMMUNOLOGY (2013)
Foxp3+ Treg Expanded from Patients with Established Diabetes Reduce Helios Expression while Retaining Normal Function Compared to Healthy Individuals
Weiting Du et al.
PLOS ONE (2013)
Global Activation of CD8+ Cytotoxic T Lymphocytes Correlates with an Impairment in Regulatory T Cells in Patients with Generalized Vitiligo
Yang Lili et al.
PLOS ONE (2012)
Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo
Janine Gotot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity
Alessandra Fierabracci
AUTOIMMUNITY REVIEWS (2011)
Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+T-Cell Compartment in the 1st Year of Human Type 1 Diabetes
Angela Hughson et al.
DIABETES (2011)
Defective Differentiation of Regulatory FoxP3+ T Cells by Small-Intestinal Dendritic Cells in Patients With Type 1 Diabetes
Ester Badami et al.
DIABETES (2011)
Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes
Alessandra Ferraro et al.
DIABETES (2011)
The potential of multimer technologies in type 1 diabetes prediction strategies
Alessandra Fierabracci
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
Stephanie A. McClymont et al.
JOURNAL OF IMMUNOLOGY (2011)
Inducible regulatory T cells (iTregs) from recent-onset type 1 diabetes subjects show increased in vitro suppression and higher ITCH levels compared with controls
Sanja Glisic et al.
CELL AND TISSUE RESEARCH (2010)
Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+ CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects
S. Alice Long et al.
DIABETES (2010)
Cutting Edge: Increased IL-17-Secreting T Cells in Children with New-Onset Type 1 Diabetes
Ashish K. Marwaha et al.
JOURNAL OF IMMUNOLOGY (2010)
Genetic, Immunologic, and Immunohistochemical Analysis of the Programmed Death 1/Programmed Death Ligand 1 Pathway in Human Systemic Lupus Erythematosus
George K. Bertsias et al.
ARTHRITIS AND RHEUMATISM (2009)
CD4+CD25+CD127low/- regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression
Li-Song Shen et al.
CLINICAL IMMUNOLOGY (2009)
APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes
Yulan Jin et al.
CLINICAL IMMUNOLOGY (2009)
Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
Amy L. Putnam et al.
DIABETES (2009)
PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV
Debora Franceschini et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis
Nuria Alonso et al.
ENDOCRINE (2009)
Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes
J. M. Lawson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-Cells
Paolo Monti et al.
DIABETES (2008)
The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells
Anya Schneider et al.
JOURNAL OF IMMUNOLOGY (2008)
CTLA-4 control over Foxp3+ regulatory T cell function
Kajsa Wing et al.
SCIENCE (2008)
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance
Xuefang Cao et al.
IMMUNITY (2007)
PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children
Ronghua Ni et al.
HUMAN GENETICS (2007)
No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes
Todd Brusko et al.
DIABETES (2007)
Galectin-1:: a key effector of regulation mediated by CD4+CD25+ T cells
Marina I. Garin et al.
BLOOD (2007)
CD39 and control of cellular immune responses
Karen M. Dwyer et al.
PURINERGIC SIGNALLING (2007)
At-Risk and Recent-Onset Type 1 Diabetic Subjects Have Increased Apoptosis in the CD4+CD25+high T-Cell Fraction
Sanja Glisic-Milosavljevic et al.
PLOS ONE (2007)
Immune regulatory T cells in siblings of children suffering from type 1 diabetes mellitus
J. Michalek et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with Type 1 diabetes
Y. Tsutsumi et al.
DIABETIC MEDICINE (2006)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells
Giorgio Raimondi et al.
JOURNAL OF IMMUNOLOGY (2006)
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
RV Parry et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes
J Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Functional defects and the influence of age on the frequency of CD4+CD25+ T-Cells in type 1 diabetes
TM Brusko et al.
DIABETES (2005)
CD4+CD25high regulatory T cells in human autoimmune diabetes
AL Putnam et al.
JOURNAL OF AUTOIMMUNITY (2005)
Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes
S Lindley et al.
DIABETES (2005)
Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II
MA Kriegel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
MJI Ansari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes
C Nielsen et al.
TISSUE ANTIGENS (2003)
The CD28 signaling pathway regulates glucose metabolism
KA Frauwirth et al.
IMMUNITY (2002)
CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells
LJ Appleman et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
